Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Propionic Acid in Multiple Sclerosis - a Placebo-controlled Randomized Double-blinded Clinical Trial

NCT06402487 is registered in ClinicalTrials.gov with Salzburger Landeskliniken as lead sponsor.

NCT NCT06402487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06402487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Propionic Acid in Multiple Sclerosis - a Placebo-controlled Randomized Double-blinded Clinical Trial
Lead sponsor
Salzburger Landeskliniken
Phase
Phase 2/3
Overall status
Completed
Start date
May 1, 2024
Completion date
October 9, 2024
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis